UPMC KANE — History
CCN 390104 | 3-year financial timeline | COVID resilience: 66/100
🛡️ Public data only — no PHI permitted on this instance.
$22M
Latest Revenue (FY2022)
+74.7%
Revenue CAGR (3yr)
-4.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $7M | $22M | $22M | +0.0% | +74.7% |
| Operating Expenses | $22M | $24M | $23M | -3.9% | +2.5% |
| Operating Margin | -100.0% | -9.2% | -4.9% | +46.8% | +0.0% |
| Net Income | $-15M | $-2M | $-1M | +46.8% | +0.0% |
| Licensed Beds | 31 | 31 | 18 | -41.9% | -23.8% |
| Total Patient Days | 885 | 1,499 | 886 | -40.9% | +0.1% |
| Medicare Day % | nan% | nan% | nan% | +nan% | +nan% |
| Medicaid Day % | 2% | 2% | 0% | -78.9% | -48.4% |
COVID Impact & Recovery
Resilience Score: 66/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +205.1% ($7M → $22M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▼ Declining
Medicare Mix▶ Stable
vs State Average ()
Revenue Growth
+74.7%
This Hospital
+7.6%
State Avg
Latest Margin
-4.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $29M | 42.7% |
| FY2024 (proj) | $36M | 90.2% |
| FY2025 (proj) | $43M | 137.8% |